Real-time PCR and immunohistochemical analysis showed that the levels of AGTR1 mRNA and protein were increased in non-BRCA1-mutated ovarian cancer compared to adjacent normal tissue (Figure 2A and B, P < 0.05). This evidence concerns the gene BRCA1 and ovarian cancer.